Collegium Pharmaceutical Inc (COLL)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 482,257 | 537,600 | 419,989 | 315,543 | 277,888 |
| Total current liabilities | US$ in thousands | 509,510 | 457,915 | 270,114 | 230,399 | 191,226 |
| Current ratio | 0.95 | 1.17 | 1.55 | 1.37 | 1.45 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $482,257K ÷ $509,510K
= 0.95
The current ratio of Collegium Pharmaceutical Inc has fluctuated over the past five years. The ratio was 1.45 as of December 31, 2020, indicating that the company had $1.45 in current assets for every $1 in current liabilities. It decreased to 1.37 by December 31, 2021, suggesting a slight weakening in the company's liquidity position.
However, Collegium Pharmaceutical Inc saw an improvement in its current ratio to 1.55 by December 31, 2022, which may indicate better short-term liquidity management. The ratio then dropped significantly to 1.17 by December 31, 2023, signaling a potential liquidity challenge or a change in the company's current asset and liability composition.
By the end of December 31, 2024, the current ratio decreased further to 0.95, which raises concerns about the company's ability to cover its short-term obligations with its current assets. Overall, Collegium Pharmaceutical Inc's current ratio has displayed variability, and it is crucial for stakeholders to monitor this metric to assess the company's short-term liquidity health.
Peer comparison
Dec 31, 2024